WASHINGTON DC, (Reuters): Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or...
WASHINGTON, (Reuters): The Bill & Melinda Gates Foundation said on Wednesday it would spend up to $120 million to kick-start the development of generic versions of...